BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) Fundamental Analysis & Valuation

FRA:BRYN • US0846707026

Current stock price

404.65 EUR
+2.6 (+0.65%)
Last:

This BRYN.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. BRYN.DE Profitability Analysis

1.1 Basic Checks

  • In the past year BRYN was profitable.
  • BRYN had a positive operating cash flow in the past year.
  • BRYN had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years BRYN had a positive operating cash flow.
BRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFBRYN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B -20B 40B 60B 80B

1.2 Ratios

  • BRYN's Return On Assets of 5.48% is fine compared to the rest of the industry. BRYN outperforms 78.95% of its industry peers.
  • BRYN has a Return On Equity of 9.33%. This is in the better half of the industry: BRYN outperforms 63.16% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 4.17%, BRYN is in line with its industry, outperforming 56.14% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BRYN is significantly below the industry average of 10.69%.
Industry RankSector Rank
ROA 5.48%
ROE 9.33%
ROIC 4.17%
ROA(3y)7.4%
ROA(5y)5.83%
ROE(3y)13.39%
ROE(5y)10.63%
ROIC(3y)4.29%
ROIC(5y)3.99%
BRYN.DE Yearly ROA, ROE, ROICBRYN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 18.03%, BRYN is in the better half of the industry, outperforming 71.93% of the companies in the same industry.
  • BRYN's Profit Margin has been stable in the last couple of years.
  • Looking at the Operating Margin, with a value of 15.63%, BRYN is in line with its industry, outperforming 52.63% of the companies in the same industry.
  • BRYN's Operating Margin has improved in the last couple of years.
  • BRYN has a Gross Margin (24.75%) which is comparable to the rest of the industry.
  • BRYN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.63%
PM (TTM) 18.03%
GM 24.75%
OM growth 3Y5.77%
OM growth 5Y5.73%
PM growth 3YN/A
PM growth 5Y0.81%
GM growth 3Y5.1%
GM growth 5Y2.53%
BRYN.DE Yearly Profit, Operating, Gross MarginsBRYN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. BRYN.DE Health Analysis

2.1 Basic Checks

  • BRYN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, BRYN has about the same amount of shares outstanding.
  • BRYN has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BRYN has an improved debt to assets ratio.
BRYN.DE Yearly Shares OutstandingBRYN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M
BRYN.DE Yearly Total Debt VS Total AssetsBRYN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B 800B 1T

2.2 Solvency

  • BRYN has an Altman-Z score of 1.37. This is a bad value and indicates that BRYN is not financially healthy and even has some risk of bankruptcy.
  • BRYN has a Altman-Z score (1.37) which is in line with its industry peers.
  • BRYN has a debt to FCF ratio of 5.15. This is a neutral value as BRYN would need 5.15 years to pay back of all of its debts.
  • BRYN has a Debt to FCF ratio of 5.15. This is in the better half of the industry: BRYN outperforms 63.16% of its industry peers.
  • BRYN has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • BRYN has a Debt to Equity ratio of 0.18. This is in the better half of the industry: BRYN outperforms 70.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.15
Altman-Z 1.37
ROIC/WACC1.25
WACC3.32%
BRYN.DE Yearly LT Debt VS Equity VS FCFBRYN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200B 400B 600B

2.3 Liquidity

  • A Current Ratio of 1.36 indicates that BRYN should not have too much problems paying its short term obligations.
  • BRYN has a Current ratio (1.36) which is in line with its industry peers.
  • BRYN has a Quick Ratio of 1.09. This is a normal value and indicates that BRYN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.09, BRYN perfoms like the industry average, outperforming 47.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.09
BRYN.DE Yearly Current Assets VS Current LiabilitesBRYN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. BRYN.DE Growth Analysis

3.1 Past

  • BRYN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.25%.
  • BRYN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.67% yearly.
  • Looking at the last year, BRYN shows a small growth in Revenue. The Revenue has grown by 0.00% in the last year.
  • The Revenue has been growing by 8.63% on average over the past years. This is quite good.
EPS 1Y (TTM)-6.25%
EPS 3Y13.85%
EPS 5Y17.67%
EPS Q2Q%-29.78%
Revenue 1Y (TTM)0%
Revenue growth 3Y7.14%
Revenue growth 5Y8.63%
Sales Q2Q%-0.72%

3.2 Future

  • The Earnings Per Share is expected to grow by 4.50% on average over the next years.
  • Based on estimates for the next years, BRYN will show a small growth in Revenue. The Revenue will grow by 5.94% on average per year.
EPS Next Y4.44%
EPS Next 2Y3.97%
EPS Next 3Y6.18%
EPS Next 5Y4.5%
Revenue Next Year-4.59%
Revenue Next 2Y-0.68%
Revenue Next 3Y-0.49%
Revenue Next 5Y5.94%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRYN.DE Yearly Revenue VS EstimatesBRYN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100B 200B 300B 400B
BRYN.DE Yearly EPS VS EstimatesBRYN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10K 20K 30K

More info and screens

Find the best growth stocksShow best growing peers

9

4. BRYN.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 0.02, the valuation of BRYN can be described as very cheap.
  • 98.25% of the companies in the same industry are more expensive than BRYN, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.87. BRYN is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 0.01 indicates a rather cheap valuation of BRYN.
  • 98.25% of the companies in the same industry are more expensive than BRYN, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of BRYN to the average of the S&P500 Index (38.51), we can say BRYN is valued rather cheaply.
Industry RankSector Rank
PE 0.02
Fwd PE 0.01
BRYN.DE Price Earnings VS Forward Price EarningsBRYN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BRYN is valued cheaply inside the industry as 85.96% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, BRYN is valued cheaply inside the industry as 98.25% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 0.03
EV/EBITDA 1.04
BRYN.DE Per share dataBRYN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100K 200K 300K 400K

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BRYN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0
PEG (5Y)0
EPS Next 2Y3.97%
EPS Next 3Y6.18%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BRYN.DE Dividend Analysis

5.1 Amount

  • No dividends for BRYN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BRYN.DE Fundamentals: All Metrics, Ratios and Statistics

BERKSHIRE HATHAWAY INC-CL B

FRA:BRYN (4/17/2026, 7:00:00 PM)

404.65

+2.6 (+0.65%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-02
Earnings (Next)05-04
Inst Owners30.99%
Inst Owner ChangeN/A
Ins Owners38.58%
Ins Owner ChangeN/A
Market Cap582.70M
Revenue(TTM)371.44B
Net Income(TTM)66.97B
Analysts44
Price Target444.74 (9.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.53%
Min EPS beat(2)-15.88%
Max EPS beat(2)4.81%
EPS beat(4)2
Avg EPS beat(4)-5.16%
Min EPS beat(4)-15.88%
Max EPS beat(4)4.81%
EPS beat(8)5
Avg EPS beat(8)5.49%
EPS beat(12)8
Avg EPS beat(12)6.31%
EPS beat(16)11
Avg EPS beat(16)6.41%
Revenue beat(2)1
Avg Revenue beat(2)-0.41%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)0.72%
Revenue beat(4)1
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-4.09%
Max Revenue beat(4)0.72%
Revenue beat(8)2
Avg Revenue beat(8)-1.86%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)6
Avg Revenue beat(16)-0.79%
PT rev (1m)0.4%
PT rev (3m)-1.4%
EPS NQ rev (1m)-1.39%
EPS NQ rev (3m)-1.39%
EPS NY rev (1m)-2.69%
EPS NY rev (3m)-2.68%
Revenue NQ rev (1m)-3.85%
Revenue NQ rev (3m)-3.92%
Revenue NY rev (1m)-4.18%
Revenue NY rev (3m)-4.31%
Valuation
Industry RankSector Rank
PE 0.02
Fwd PE 0.01
P/S 0
P/FCF 0.03
P/OCF 0.01
P/B 0
P/tB 0
EV/EBITDA 1.04
EPS(TTM)26253.88
EY6488.05%
EPS(NY)27419.77
Fwd EY6776.17%
FCF(TTM)14760
FCFY3647.6%
OCF(TTM)27094.7
OCFY6695.84%
SpS218933.31
BVpS422854.9
TBVpS353354
PEG (NY)0
PEG (5Y)0
Graham Number499786 (123410.69%)
Profitability
Industry RankSector Rank
ROA 5.48%
ROE 9.33%
ROCE 5.14%
ROIC 4.17%
ROICexc 4.37%
ROICexgc 5.16%
OM 15.63%
PM (TTM) 18.03%
GM 24.75%
FCFM 6.74%
ROA(3y)7.4%
ROA(5y)5.83%
ROE(3y)13.39%
ROE(5y)10.63%
ROIC(3y)4.29%
ROIC(5y)3.99%
ROICexc(3y)4.49%
ROICexc(5y)4.21%
ROICexgc(3y)5.35%
ROICexgc(5y)5.06%
ROCE(3y)5.29%
ROCE(5y)4.92%
ROICexgc growth 3Y2.7%
ROICexgc growth 5Y6.05%
ROICexc growth 3Y3.93%
ROICexc growth 5Y7.05%
OM growth 3Y5.77%
OM growth 5Y5.73%
PM growth 3YN/A
PM growth 5Y0.81%
GM growth 3Y5.1%
GM growth 5Y2.53%
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 5.15
Debt/EBITDA 1.8
Cap/Depr 155.29%
Cap/Sales 5.63%
Interest Coverage 11.39
Cash Conversion 64.28%
Profit Quality 37.39%
Current Ratio 1.36
Quick Ratio 1.09
Altman-Z 1.37
F-Score5
WACC3.32%
ROIC/WACC1.25
Cap/Depr(3y)152.78%
Cap/Depr(5y)144.82%
Cap/Sales(3y)5.36%
Cap/Sales(5y)5.2%
Profit Quality(3y)27.13%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.25%
EPS 3Y13.85%
EPS 5Y17.67%
EPS Q2Q%-29.78%
EPS Next Y4.44%
EPS Next 2Y3.97%
EPS Next 3Y6.18%
EPS Next 5Y4.5%
Revenue 1Y (TTM)0%
Revenue growth 3Y7.14%
Revenue growth 5Y8.63%
Sales Q2Q%-0.72%
Revenue Next Year-4.59%
Revenue Next 2Y-0.68%
Revenue Next 3Y-0.49%
Revenue Next 5Y5.94%
EBIT growth 1Y-4.75%
EBIT growth 3Y13.32%
EBIT growth 5Y14.85%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y115.58%
FCF growth 3Y4.59%
FCF growth 5Y-1.32%
OCF growth 1Y50.26%
OCF growth 3Y7.17%
OCF growth 5Y2.94%

BERKSHIRE HATHAWAY INC-CL B / BRYN.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BERKSHIRE HATHAWAY INC-CL B?

ChartMill assigns a fundamental rating of 5 / 10 to BRYN.DE.


What is the valuation status of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?

ChartMill assigns a valuation rating of 9 / 10 to BERKSHIRE HATHAWAY INC-CL B (BRYN.DE). This can be considered as Undervalued.


How profitable is BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) stock?

BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for BRYN stock?

The Earnings per Share (EPS) of BERKSHIRE HATHAWAY INC-CL B (BRYN.DE) is expected to grow by 4.44% in the next year.